Drug Type Recombinant polypeptide, Biosimilar |
Synonyms oral Semaglutide, Semaglutide Biosimilar (SAM CHUN DANG PHARM Co., Ltd.), 司美格鲁肽 生物类似药(SAM CHUN DANG PHARM Co., Ltd.) |
Target |
Action agonists |
Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |

| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Obesity | Clinical | South Korea | 22 Jan 2025 |






